Divergent Effects of COVID-19 Pandemic on Reported Adverse Events for Percutaneous Aortic Valve Prostheses and Non-Allograft Tissue Valves

Am J Cardiol. 2022 Mar 15:167:151-153. doi: 10.1016/j.amjcard.2021.12.005. Epub 2022 Jan 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 / epidemiology*
  • Heart Valve Prosthesis / adverse effects*
  • Humans
  • Mortality*
  • Product Surveillance, Postmarketing*
  • Prosthesis Failure / trends*
  • SARS-CoV-2
  • Transcatheter Aortic Valve Replacement*
  • United States / epidemiology
  • United States Food and Drug Administration